ATE325809T1 - Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl- amino-5-phenyl-pentansäure - Google Patents
Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl- amino-5-phenyl-pentansäureInfo
- Publication number
- ATE325809T1 ATE325809T1 AT01943442T AT01943442T ATE325809T1 AT E325809 T1 ATE325809 T1 AT E325809T1 AT 01943442 T AT01943442 T AT 01943442T AT 01943442 T AT01943442 T AT 01943442T AT E325809 T1 ATE325809 T1 AT E325809T1
- Authority
- AT
- Austria
- Prior art keywords
- amino
- pentoric
- leucyl
- tert
- hydroxy
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 150000001408 amides Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0012795.1A GB0012795D0 (en) | 2000-05-25 | 2000-05-25 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE325809T1 true ATE325809T1 (de) | 2006-06-15 |
Family
ID=9892401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01943442T ATE325809T1 (de) | 2000-05-25 | 2001-05-23 | Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl- amino-5-phenyl-pentansäure |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20030166572A1 (de) |
| EP (1) | EP1290012B1 (de) |
| JP (1) | JP2003533541A (de) |
| AT (1) | ATE325809T1 (de) |
| AU (1) | AU2001266019A1 (de) |
| CA (1) | CA2405871A1 (de) |
| DE (1) | DE60119514T2 (de) |
| ES (1) | ES2261422T3 (de) |
| GB (1) | GB0012795D0 (de) |
| PT (1) | PT1290012E (de) |
| WO (1) | WO2001089282A2 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20040762A1 (es) * | 2002-11-27 | 2004-11-06 | Elan Pharm Inc | Ureas substituidas y carbamatos utiles para el tratamiento de la enfermedad de alzheimer |
| GB0504950D0 (en) * | 2005-03-10 | 2005-04-20 | Novartis Ag | Organic compositions |
| US7919468B2 (en) | 2005-04-07 | 2011-04-05 | Centre National De La Recherche Scientifique (C.N.R.S.) | Compounds useful as modulators of the proteasome activity |
| JP2011513278A (ja) * | 2008-02-28 | 2011-04-28 | ノバルティス アーゲー | カンナビノイド受容体結合化合物およびオピオイドを含む組合せ |
| EP2399129B1 (de) | 2009-02-20 | 2015-11-25 | Michael P. Lisanti | Verfahren zur diagnose bzw. prognose eines neoplasmas einschliesslich der bestimmung des expressionsgrads eines proteins in stromazellen neben dem neoplasma |
| GB2523211B (en) | 2012-01-27 | 2020-03-18 | Univ Jefferson | MCT protein inhibitor-related prognostic and therapeutic methods |
| EP2986290A4 (de) | 2013-04-19 | 2017-01-04 | Thomas Jefferson University | Caveolin-1-verwandte verfahren zur behandlung von glioblastom mit temozolomid |
| WO2019231935A1 (en) * | 2018-05-29 | 2019-12-05 | Omeros Corporation | Masp-2 inhibitors and methods of use |
| AU2020395306B2 (en) | 2019-12-04 | 2025-04-24 | Omeros Corporation | MASP-2 inhibitors and methods of use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5538997A (en) * | 1993-03-12 | 1996-07-23 | Sandoz Ltd. | 2,4-diamino-3-hydroxycarboxylic acid derivatives |
| EP0982317A1 (de) * | 1998-08-26 | 2000-03-01 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Bivalente Proteasome Inhibitore |
| ATE270268T1 (de) * | 1999-04-27 | 2004-07-15 | Novartis Pharma Gmbh | 2,4-diamino-3-hydroxycarboxylsäurederivate als proteasome inhibitoren |
-
2000
- 2000-05-25 GB GBGB0012795.1A patent/GB0012795D0/en not_active Ceased
-
2001
- 2001-05-23 DE DE60119514T patent/DE60119514T2/de not_active Expired - Fee Related
- 2001-05-23 EP EP01943442A patent/EP1290012B1/de not_active Expired - Lifetime
- 2001-05-23 CA CA002405871A patent/CA2405871A1/en not_active Abandoned
- 2001-05-23 AU AU2001266019A patent/AU2001266019A1/en not_active Abandoned
- 2001-05-23 JP JP2001585538A patent/JP2003533541A/ja active Pending
- 2001-05-23 AT AT01943442T patent/ATE325809T1/de not_active IP Right Cessation
- 2001-05-23 ES ES01943442T patent/ES2261422T3/es not_active Expired - Lifetime
- 2001-05-23 WO PCT/EP2001/005952 patent/WO2001089282A2/en not_active Ceased
- 2001-05-23 US US10/258,901 patent/US20030166572A1/en not_active Abandoned
- 2001-05-23 PT PT01943442T patent/PT1290012E/pt unknown
-
2006
- 2006-05-15 US US11/434,398 patent/US20060205673A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2001266019A1 (en) | 2001-12-03 |
| US20030166572A1 (en) | 2003-09-04 |
| PT1290012E (pt) | 2006-09-29 |
| EP1290012A2 (de) | 2003-03-12 |
| JP2003533541A (ja) | 2003-11-11 |
| WO2001089282A3 (en) | 2002-05-10 |
| US20060205673A1 (en) | 2006-09-14 |
| GB0012795D0 (en) | 2000-07-19 |
| EP1290012B1 (de) | 2006-05-10 |
| WO2001089282A2 (en) | 2001-11-29 |
| DE60119514D1 (de) | 2006-06-14 |
| DE60119514T2 (de) | 2006-10-05 |
| ES2261422T3 (es) | 2006-11-16 |
| CA2405871A1 (en) | 2001-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0113838A (pt) | Derivados de n-fenil-2-pirimidina-amina | |
| MY139302A (en) | Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof | |
| ATE307810T1 (de) | Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren | |
| ATE504579T1 (de) | Antivirale mittel | |
| SE0101387D0 (sv) | Novel compounds | |
| BR0315547A (pt) | Derivados de quinolina como antagonistas de crth2 | |
| MXPA04000577A (es) | Derivados de dolastatina 10. | |
| ATE361287T1 (de) | Neue indol-2-on derivate | |
| WO2003053368A3 (en) | Chalcone derivatives and their use to treat diseases | |
| DE60003863D1 (de) | Dioxocyclopentylhydroxamsäure | |
| ATE388951T1 (de) | Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes | |
| BRPI0418251B8 (pt) | fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo | |
| CY1108871T1 (el) | Υποκατεστημενα παραγωγα αμινο-φουραν-2-υλ-οξεικου οξεος και αμινο-θειεν-2-οξεικου οξεος και η χρησιμοποιηση τους για τη θεραπεια ημικρανιας ή πονου | |
| TNSN04203A1 (en) | Benzoxazinone-derived compounds, their preparation and use as medicaments | |
| DE60045508D1 (de) | Dalda-analoge und ihre verwendung | |
| MY135218A (en) | 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases | |
| ATE300541T1 (de) | Pyrazolopyridinderivate | |
| SE0302139D0 (sv) | Novel compounds | |
| DE60001586D1 (de) | Diphenyl-piperidin derivate | |
| SE0301701D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
| SE9804212D0 (sv) | Compounds | |
| MXPA05010020A (es) | Derivados de oxamida. | |
| SE0301699D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
| ATE267816T1 (de) | Tan-1057 derivate | |
| DE60119514D1 (de) | Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentansäure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1290012 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |